WHOLE SHINE MEDICAL(002622)
Search documents
皓宸医疗(002622) - 2020 Q2 - 季度财报
2020-08-27 16:00
Financial Performance - The company's operating revenue for the first half of 2020 was ¥29,632,396.01, a decrease of 56.18% compared to ¥67,628,046.01 in the same period last year[17]. - The net profit attributable to shareholders was a loss of ¥32,419,460.31, representing a 120.50% increase in loss compared to a loss of ¥14,702,775.47 in the previous year[17]. - The total profit for the period was -¥32,383,605.73, with a net profit attributable to shareholders of -¥32,419,460.31[37]. - The basic and diluted earnings per share were both -¥0.0386, reflecting a 120.54% increase in loss per share compared to -¥0.0175 in the same period last year[17]. - The total comprehensive loss for the first half of 2020 was ¥28,851,587.81, compared to a loss of ¥12,136,722.72 in the first half of 2019, indicating a worsening of 137.5%[142]. - The net loss for the first half of 2020 was ¥32,419,460.31, compared to a net loss of ¥14,426,844.19 in the first half of 2019, representing a deterioration of 125.5%[141]. Cash Flow and Liquidity - The net cash flow from operating activities improved to ¥11,779,170.25, a significant increase of 158.53% from a negative cash flow of ¥20,124,563.03 in the same period last year[17]. - The cash inflow from investment activities increased significantly to ¥64,048,993.15 in 2020, up from ¥22,501,787.75 in 2019, marking an increase of approximately 184%[150]. - The ending cash and cash equivalents balance increased to ¥83,901,505.05 in 2020 from ¥31,323,239.46 in 2019, reflecting a growth of approximately 168%[150]. - The company reported a credit impairment loss of ¥-35,177,451.37, which accounted for 108.63% of total profit[50]. - The company received tax refunds of ¥1,258,495.05 in 2020, down from ¥4,108,156.23 in 2019, indicating a decrease of approximately 69%[149]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,728,213,020.58, a decrease of 2.15% from ¥1,766,200,608.52 at the end of the previous year[17]. - The total liabilities at the end of the first half of 2020 were approximately 287.42 million, showing a decrease from the previous year[162]. - Current liabilities totaled CNY 390,513,063.25, down from CNY 469,547,128.97, indicating a reduction of about 16.83%[133]. - Non-current liabilities increased to CNY 90,744,609.25 from CNY 12,631,741.62, showing a significant rise of approximately 617.56%[133]. - The total owner's equity decreased to CNY 1,246,955,348.08 from CNY 1,284,021,737.93, representing a decline of about 2.89%[134]. Business Operations and Strategy - The company primarily engages in the research, production, and sales of permanent magnet switches and high/low voltage switchgear, as well as software development and services[25]. - The company has established a marketing network across over 20 provinces and cities in China, providing comprehensive pre-sale, in-sale, and after-sale services[25]. - The company emphasizes that future operational plans and targets do not constitute profit forecasts and are subject to market conditions[4]. - The company plans to focus on enhancing its capital structure and improving profitability in the upcoming periods[156]. - The company aims to enhance its operational efficiency and explore potential mergers and acquisitions to drive growth[161]. Subsidiaries and Investments - The company’s subsidiary, Zhiyong Technology, focuses on software products in four key areas: government big data, smart market supervision, smart IoT, and social credit services[26]. - The company’s subsidiary, Rongyu Huatuo, focuses on financing leasing and trade financing through accounts receivable management, maintaining existing business without expansion due to regulatory impacts[28]. - The company has initiated the liquidation of subsidiaries that have not generated substantial revenue, aiming to optimize asset structure and reduce management costs[39]. - The company reported a total investment of 400,096,775.18 RMB in financial assets, with a loss of 37,193,315.18 RMB during the reporting period[60]. Shareholder Information - The total number of shares remains at 840 million, with no changes in the shareholding structure reported[110]. - The total number of common shareholders at the end of the reporting period was 44,907[112]. - The largest shareholder, Guangzhou Huiyin Rifen Investment Partnership, holds 200,000,000 shares, representing 23.81% of total shares[113]. - The company plans not to distribute cash dividends or issue bonus shares for the half-year period[73]. Regulatory and Compliance - The financial report for the first half of 2020 was not audited[129]. - The company has not engaged in any significant equity or non-equity investments during the reporting period[59][64]. - The company has not reported any violations regarding external guarantees[95]. - The company confirmed that any partial disposal of equity investments that does not result in loss of control will adjust capital reserves accordingly[188]. Risk Management - The company faces risks related to macroeconomic conditions and the long investment return period, which may affect expected returns[69]. - The company has assessed that its ability to continue as a going concern is good, with no significant doubts regarding its operational capability in the next 12 months[175]. - The company reported credit impairment losses of ¥35,177,451.37, a significant increase from ¥-107,410.75 in the previous year[141].
皓宸医疗(002622) - 2020 Q1 - 季度财报
2020-04-29 16:00
Financial Performance - The company's operating revenue for Q1 2020 was ¥8,583,632.58, a decrease of 78.47% compared to ¥39,877,498.75 in the same period last year[7] - The net profit attributable to shareholders was -¥1,363,380.38, an improvement of 85.77% from -¥9,581,679.68 year-on-year[7] - The basic earnings per share were -¥0.0016, showing an improvement of 85.76% from -¥0.0114 in the same period last year[7] - Operating revenue for the period was ¥8,583,632.58, a decrease of 78.47% year-on-year, mainly due to the absence of advertising and consulting service income after the disposal of a subsidiary[14] - Operating costs decreased by 76.13% to ¥4,335,612.28, reflecting a reduction in business volume during the reporting period[14] - The net profit for Q1 2020 was a loss of CNY 1,363,380.38, compared to a loss of CNY 9,032,379.56 in the same period last year[41] - The net profit for the period was CNY 3,199,507.74, a significant improvement from a net loss of CNY 2,153,194.46 in the same period last year[45] Cash Flow - The net cash flow from operating activities was ¥6,139,924.33, a significant increase of 148.18% compared to -¥12,743,347.22 in the previous year[7] - The net cash flow from investing activities was -¥206,858.90, an increase of 98.38% compared to the previous year, due to significantly reduced external investment expenditures[14] - The net cash flow from financing activities was -¥12,386,312.15, an increase of 55.82% year-on-year, primarily due to higher bank loan repayments in the previous period[14] - The cash flow from operating activities generated a net cash inflow of CNY 6,139,924.33, compared to a net outflow of CNY 12,743,347.22 in the previous period[48] - Total cash inflow from operating activities was 13,413,075.11 yuan, while cash outflow was 14,014,258.86 yuan, resulting in a net cash outflow of 601,183.75 yuan[50] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,769,321,049.15, a slight increase of 0.18% from ¥1,766,200,608.52 at the end of the previous year[7] - The total current assets as of March 31, 2020, amounted to ¥481,646,691.36, a decrease from ¥492,324,057.80 as of December 31, 2019, reflecting a decline of approximately 2.4%[30] - The total liabilities as of March 31, 2020, were ¥483,062,496.05, slightly up from ¥482,178,870.59, indicating a marginal increase of about 0.2%[33] - The total assets of the company as of January 1, 2020, were 1,766,200,608.52 yuan, with total liabilities amounting to 482,178,870.59 yuan[54] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 46,602[10] - The largest shareholder, Guangzhou Huiyin Rifen Investment Partnership, held 23.81% of the shares, amounting to 200,000,000 shares[10] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[11] Non-Recurring Items - The company recognized non-recurring gains and losses totaling ¥612,965.75, primarily from government subsidies and VAT refunds[8] Inventory and Receivables - The ending balance of accounts receivable decreased by 67.79% to ¥6,215,842.65 due to the maturity of notes and a decrease in new sales of switch products[14] - The ending balance of prepayments increased by 380.13% to ¥9,342,731.57, primarily due to increased material purchases during the reporting period[14] - Accounts receivable decreased to CNY 8,131,759.52 from CNY 10,640,874.92[36] - Inventory increased to ¥52,067,417.02 from ¥41,537,356.61, reflecting a growth of approximately 25.3%[31] Financial Management - The company reported no overdue commitments from actual controllers, shareholders, or related parties during the reporting period[18] - There were no derivative investments or violations regarding external guarantees during the reporting period, reflecting a conservative financial strategy[24][25] - The company reported no overdue amounts in its entrusted financial management activities, indicating effective management of financial risks[23] Changes in Control and Agreements - The company terminated share transfer agreements with Shanghai Chengyi and Anji Xingfeng, clarifying the end of negotiations regarding share transfers[15] - The actual controller of the company is expected to change following the completion of the equity changes involving Beijing Shoutuo Ronghui[16] Other Financial Information - The company executed new revenue and leasing standards starting in 2020, which may impact future financial reporting[58] - The first quarter report for 2020 was not audited, which may affect the reliability of the financial data presented[59]
皓宸医疗(002622) - 2019 Q4 - 年度财报
2020-04-29 16:00
Financial Performance - The company reported a total revenue of 1.2 billion RMB for the year 2019, representing a year-on-year increase of 15%[11] - The net profit attributable to shareholders was 150 million RMB, which is a 10% increase compared to the previous year[11] - The company's operating revenue for 2019 was ¥155,321,874.62, a decrease of 63.23% compared to ¥422,405,637.01 in 2018[17] - The net profit attributable to shareholders for 2019 was ¥7,440,930.97, down 79.80% from ¥36,843,238.80 in 2018[17] - The company reported a basic earnings per share of ¥0.0089 for 2019, a decline of 77.75% from ¥0.040 in 2018[17] - The company reported a significant increase in cash flow from operating activities, indicating improved operational efficiency and financial health[17] - The net cash flow from operating activities increased by 437.96% to ¥22,750,889.82 in 2019, compared to ¥4,229,099.44 in 2018[17] - The company reported a total of ¥191,379,736.39 in restricted assets, primarily due to collateral for loans[77] - The company reported an investment income of ¥56,028,830.23, accounting for 441.75% of total profit, primarily from its stake in Fushun Bank[71] Business Strategy and Expansion - The company plans to expand its business into innovative technology and financial services, aiming for a 20% growth in these sectors over the next year[15] - The company aims to enhance its market presence through strategic partnerships and acquisitions, targeting a 30% increase in market share by 2021[15] - The company has established over ten subsidiaries, diversifying its operations into big data analysis and new retail sectors[15] - The company is focusing on R&D for new products in smart electrical equipment, with an investment of 100 million RMB allocated for this purpose in 2020[15] - The company aims to expand its product categories and enhance competitiveness through ongoing R&D efforts, which are expected to lower procurement costs[62] Risk Management and Compliance - The company has identified no significant risks that could adversely affect its production, financial status, or profitability[4] - The company is committed to strict risk management and scientific investment decisions to navigate macroeconomic and policy challenges[97] - The company has been publicly reprimanded by regulatory authorities for administrative violations, including environmental and safety issues[121] - The company received a public reprimand from the Shenzhen Stock Exchange for regulatory violations[186] Operational Efficiency and Cost Management - The company focused on cost management, leading to a reduction in expenses and improved operational efficiency across its three business segments[43] - In 2019, the total sales expenses decreased by 36.78% to ¥14,747,154.39 compared to ¥23,325,079.42 in 2018, primarily due to reduced expenditures and the exclusion of certain subsidiaries from the consolidation scope[58] - Management expenses fell by 51.35% to ¥77,035,558.96 in 2019 from ¥158,335,807.86 in 2018, attributed to decreased spending and the exclusion of specific subsidiaries post-equity transfer[58] Research and Development - The company has implemented a sales management model that combines regional and industry approaches, enhancing its presence in clean energy sectors[28] - The company completed several R&D projects in 2019, including the development of a 12KV-1250A high-voltage permanent magnet intelligent vacuum circuit breaker, which is aimed at enhancing product intelligence and digital capabilities[61] - The company’s innovative technology segment, Zhiyong Technology, has developed multiple products for various government agencies, including enterprise credit supervision systems and smart fire IoT platforms[38] - The number of R&D personnel increased to 109 in 2019, representing 24.83% of the total workforce, up from 13.29% in 2018[65] Shareholder and Governance Structure - The total number of shares outstanding is 840 million, with 839,976,750 shares being unrestricted[152] - The company does not have a controlling shareholder, as the largest shareholder does not have an actual controller[160] - The company’s actual controller is a domestic natural person, with no changes in the controlling shareholder during the reporting period[161] - The company has a comprehensive remuneration management system based on performance evaluation[187] Subsidiaries and Equity Transactions - The company completed the transfer of 100% equity of Zhongyuan Hengxin Industrial Group Co., Ltd. to Guoda Yongtai Investment Holding Group Co., Ltd. in April 2019[93] - The company announced the transfer of equity in its subsidiary Rongyu Interactive, reflecting strategic adjustments in its investment portfolio[147] - The company plans to complete the buyback of remaining shares of Shanghai Chen Shang by December 31, 2020, with a buyback price of RMB 46 million[92] Employee and Talent Management - The total number of employees is 439, with 205 in production, 83 in technical roles, 59 in sales, 20 in finance, and 72 in administration[190][191] - Employee education levels include 248 with vocational education or below, 96 with associate degrees, and 95 with bachelor's degrees or higher[191] - The company has implemented a compensation policy linking employee income to company performance, ensuring fairness across different departments and positions[192] Financial Reporting and Accounting Standards - The company will implement new accounting standards starting January 1, 2020, without retrospective adjustments affecting 2019 financial indicators[111] - The company plans to prepare consolidated financial statements according to the revised reporting format from 2019 onwards[110] - The company has not made any changes to accounting policies that would affect the financial statements for the reporting period[109] Social Responsibility - The company actively engaged in social responsibility initiatives, focusing on energy conservation, environmental protection, and safety management[139] - The company has implemented measures for the employment of disabled individuals and actively participates in social welfare activities[139]
皓宸医疗(002622) - 2019 Q3 - 季度财报
2019-10-30 16:00
Financial Performance - Operating revenue for the reporting period was CNY 29,544,061.68, down 74.64% year-on-year, and CNY 97,172,107.69 for the year-to-date, down 66.03% compared to the same period last year[7] - Net profit attributable to shareholders was CNY 215,395.72, a decrease of 98.78% year-on-year, with a year-to-date net loss of CNY 14,487,379.75, down 174.06%[7] - Basic and diluted earnings per share were CNY 0.0003, a decrease of 98.58% year-on-year, with a year-to-date loss per share of CNY -0.0172, down 173.82%[7] - The net profit for the period was a loss of CNY 14,442,647.78, compared to a profit of CNY 42,786,097.31 in the previous year[52] - The net profit for the third quarter of 2019 was CNY 16,084,445.30, compared to a net loss of CNY 19,540,657.06 in the same period last year, indicating a significant turnaround[56] Cash Flow - The net cash flow from operating activities was CNY 3,166,263.33, down 92.20% year-on-year, and CNY -16,958,299.70 for the year-to-date, down 148.16%[7] - The cash flow from operating activities showed a net outflow of CNY 16,958,299.70, contrasting with a net inflow of CNY 35,209,340.95 in the same quarter last year[61] - The net cash flow from operating activities decreased by 52.17 million RMB, reflecting a significant decline in sales collections compared to the previous year[17] - The cash inflow from investment activities was 190,100,572.92 CNY, while cash outflow was 214,565,733.11 CNY, leading to a net cash flow of -24,465,160.19 CNY[64] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,786,585,561.48, a decrease of 4.52% compared to the end of the previous year[7] - The total liabilities decreased from ¥526,918,994.40 to ¥496,827,393.54, representing a reduction of about 5.7%[36] - The company's cash and cash equivalents dropped significantly from ¥99,804,517.63 to ¥32,921,079.69, a decline of approximately 67%[33] - The total current liabilities were CNY 848,234,072.86, including short-term borrowings of CNY 130,000,000.00[74] Shareholder Information - The total number of shareholders at the end of the reporting period was 63,895, with the largest shareholder holding 23.81% of the shares[10] - The largest shareholder, Guangzhou Huiyin Rifen Investment Partnership, held 200,000,000 shares[12] Operational Metrics - The operating costs decreased by 76.66%, resulting in a reduction of 120.88 million RMB, in line with the decrease in operating revenue[17] - The total operating costs amounted to CNY 40,974,486.50, a decrease from CNY 130,501,883.28 year-over-year[43] - The total operating revenue for the first three quarters was CNY 97,172,107.69, a decrease of 66.0% compared to CNY 286,013,061.43 in the same period last year[50] Non-Operating Income and Expenses - Non-operating income included government subsidies of CNY 1,245,941.00, which are closely related to the company's business[8] - The company incurred tax expenses of CNY 3,360,879.35, compared to a tax benefit of CNY -9,013,316.06 in the previous year[52] Compliance and Governance - The company reported no non-compliance with external guarantees during the reporting period[25] - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[26] - The company has not undergone an audit for the third quarter report[76] - The report indicates a significant focus on improving financial reporting and compliance with new regulations[76]
皓宸医疗(002622) - 2019 Q2 - 季度财报
2019-08-30 16:00
Financial Performance - The company's operating revenue for the first half of 2019 was ¥67,628,046.01, a decrease of 60.10% compared to ¥169,511,762.60 in the same period last year[17]. - The net profit attributable to shareholders was a loss of ¥14,702,775.47, representing a decline of 885.92% from a profit of ¥1,870,770.37 in the previous year[17]. - The net cash flow from operating activities was negative at ¥20,124,563.03, an increase in loss of 273.55% compared to a loss of ¥5,387,389.65 in the same period last year[18]. - Basic and diluted earnings per share were both -¥0.0175, a decrease of 895.45% from ¥0.0022 in the previous year[18]. - Total assets at the end of the reporting period were ¥1,787,776,330.93, down 4.46% from ¥1,871,234,376.91 at the end of the previous year[18]. - The net assets attributable to shareholders increased slightly by 0.74% to ¥1,289,951,672.02 from ¥1,280,529,058.29 at the end of the previous year[18]. - The company reported a total of ¥294,501.83 in non-recurring gains and losses during the reporting period[21]. - The company experienced a significant increase in non-recurring losses, with a 8,341.39% increase in net profit attributable to shareholders after deducting non-recurring gains and losses[17]. - The company achieved operating revenue of ¥67,628,046.01, a decrease of 60.10% compared to the same period last year, primarily due to macroeconomic impacts[39]. - The net profit attributable to shareholders was -¥14,702,775.47, reflecting a significant decline compared to the previous year[39]. Business Segments - The company operates in three main business segments: industrial, innovative technology, and financial services, aiming to integrate industry scenarios with big data technology and financial service platforms[24]. - The industrial segment focuses on the research, production, and sales of permanent magnet switches and high/low voltage switchgear, with a marketing network covering over 20 provinces[25]. - The innovative technology segment includes subsidiaries that provide data-driven digital marketing and advertising services, enhancing customer acquisition strategies[27]. - The financial services segment primarily involves trade financing through accounts receivable factoring, with a focus on credit risk assessment and management[29]. - The financial services segment is expanding its leasing business, particularly in transportation and equipment manufacturing sectors, with a focus on large private and state-owned enterprises[31]. Strategic Initiatives - The company plans not to distribute cash dividends or issue bonus shares[6]. - The company has optimized its asset structure by liquidating subsidiaries that did not generate substantial revenue, improving overall operational efficiency[31]. - The company is committed to enhancing collaboration among its business segments to improve competitive advantages and operational synergies[31]. - The company is focusing on cost management and has implemented measures to enhance internal control, aiming for more efficient operations across its three business segments[40]. - The company aims to strengthen its market position by focusing on long-term customer relationships and expanding its client base in the industrial sector[26]. - The company is actively seeking to expand its customer base while maintaining stable existing customer resources in its industrial and innovative technology segments[35]. Investment and Financial Management - The company has increased its investment in Beijing Wantai Zhonglian Technology Co., Ltd. as part of its equity assets[32]. - The company has established a new private equity fund in collaboration with Shanghai Xianglan Asset Management Co., Ltd. to seize strategic investment opportunities[34]. - The company has made a total investment of 260,200,000 CNY in financial assets, with a fair value change of 10,920.00 CNY during the reporting period[62]. - The company reported a fair value loss of ¥49,200.00, representing 0.41% of total profit, attributed to the fair value changes of financial assets[52]. - The company has pledged assets worth ¥19,088.56 million as collateral for loans, with a loan amount of ¥130 million from Zhongrong International Trust Co., Ltd.[56]. Operational Challenges - The company faced public condemnation from regulatory authorities due to inaccurate information disclosed in a strategic cooperation agreement[84]. - The company reported a significant decrease in cash inflows from other operating activities, which fell to CNY 17,837,821.04 from CNY 109,766,204.45 in the previous year[145]. - The company’s total revenue from subsidiaries in the reporting period was significantly impacted by market competition and economic conditions[71]. - The company has not reported any new product launches or technological advancements during this period[160]. - The company has not experienced any significant environmental protection issues and is not classified as a key pollutant discharge unit by environmental authorities[101]. Governance and Compliance - The half-year financial report has not been audited[81]. - The company will enhance personnel training on relevant laws and regulations to improve operational standards and information disclosure quality[85]. - There were no major litigation or arbitration matters during the reporting period[83]. - The company has not engaged in any significant related party transactions during the reporting period[90]. - The company has not provided any guarantees to shareholders, actual controllers, or their related parties[98]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 56,116[115]. - The largest shareholder, Guangzhou Huiyin Rifen Investment Partnership, holds 23.81% of the shares, totaling 200,000,000 RMB common shares[115]. - The second-largest shareholder, Shaanxi International Trust Co., Ltd., holds 3.84% of the shares, totaling 32,263,200 RMB common shares[115]. - The company reported a total external guarantee amount of 45,000,000 RMB, with an actual guarantee balance of 40,604,690 RMB, representing 31.48% of the company's net assets[98]. - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period[117].
皓宸医疗(002622) - 2019 Q1 - 季度财报
2019-04-28 16:00
Financial Performance - The company's operating revenue for Q1 2019 was ¥39,877,498.75, representing a 47.65% increase compared to ¥27,008,944.61 in the same period last year[8]. - The net profit attributable to shareholders was -¥9,581,679.68, a decrease of 15.26% from -¥8,312,871.88 year-on-year[8]. - The basic earnings per share for the period was -¥0.0114, a decrease of 15.15% from -¥0.0099 in the same period last year[8]. - The company reported a net profit loss of ¥9,032,379.56 for Q1 2019, compared to a loss of ¥4,729,248.60 in the same period last year, indicating a year-over-year increase in losses of approximately 91.5%[45]. - The total comprehensive income for the current period was -¥9,032,379.56, compared to -¥4,729,248.60 in the previous year, marking an increase in comprehensive losses of about 91.5%[46]. Cash Flow - The net cash flow from operating activities was -¥12,743,347.22, a significant decline of 188.19% compared to ¥14,450,282.39 in the previous year[8]. - Cash flow from operating activities included cash received from sales of goods and services amounting to ¥44,784,625.47, compared to ¥25,294,406.94 in the previous period, indicating a significant increase of approximately 77.1%[51]. - The total cash inflow from operating activities was 59,454,919.50 CNY, while total cash outflow was 72,198,266.72 CNY, leading to a net cash flow from operating activities of -12,743,347.22 CNY[52]. - The ending balance of cash and cash equivalents is ¥46,344,992.08, a decrease of 53.56% compared to the end of the previous year, due to debt repayment, investment in financial products, and net cash outflow from operations[16]. - The cash outflow for paying dividends and interest was 8,388,977.53 CNY, slightly lower than 8,747,064.84 CNY in the previous period[53]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,834,857,868.33, down 1.94% from ¥1,871,234,376.91 at the end of the previous year[8]. - The company's current assets totaled CNY 502,717,752.43, down from CNY 548,477,566.83 at the end of 2018, indicating a decline of approximately 8.6%[35]. - Total liabilities decreased to CNY 843,052,194.31 from CNY 855,865,989.57 at the end of 2018, reflecting a reduction in financial obligations[42]. - Current liabilities reached CNY 848,234,072.86, including short-term borrowings of CNY 130,000,000.00[63]. - The company's total liabilities increased, impacting its cash flow and financial stability, although specific figures were not detailed in the provided content[58]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 56,542[12]. - The largest shareholder, Guangzhou Huiyin Rifen Investment Partnership, held 23.81% of the shares, totaling 200,000,000 shares[12]. - The company has a total of CNY 1,280,529,058.29 in equity attributable to shareholders of the parent company[61]. Research and Development - R&D expenses for the period are ¥2,685,227.11, reflecting a 30.33% increase year-on-year as the company intensifies its R&D efforts[16]. - Research and development expenses for Q1 2019 were CNY 2,685,227.11, up from CNY 2,060,268.43 in Q1 2018, indicating an increased focus on innovation[43]. Strategic Initiatives - The company has signed a cooperation framework agreement with Alibaba Group, focusing on e-commerce, new retail, big data, and AI solutions, although formal agreements are still pending[17]. - The company plans to transfer 100% equity of Zhongyuan Hengxin Industrial Group to optimize its asset structure and support its main business upgrade[20]. - The company has not yet signed formal agreements for further cooperation with Alibaba, indicating that the collaboration is still in the preliminary stages[17]. Other Financial Metrics - The company reported non-recurring gains and losses totaling ¥941,808.61, primarily from the disposal of obsolete inventory and government subsidies[9]. - The company incurred management expenses of ¥8,594,276.56, down from ¥11,001,518.69 in the previous period, showing a reduction of approximately 21.9%[47]. - Financial expenses totaled ¥6,894,546.74, a decrease from ¥8,219,665.63 in the previous year, reflecting a reduction of about 16.1%[47]. - The company recorded an investment income of ¥13,114,006.03, compared to ¥12,900,921.58 in the previous year, indicating a slight increase of approximately 1.7%[48].
皓宸医疗(002622) - 2018 Q4 - 年度财报
2019-04-28 16:00
Financial Performance - The company reported a total revenue of 1.2 billion RMB for the year 2018, representing a year-on-year increase of 15%[13]. - The net profit attributable to shareholders was 150 million RMB, which is a 10% increase compared to the previous year[13]. - The company's operating revenue for 2018 was ¥422,405,637.01, representing a 116.70% increase compared to ¥194,929,409.68 in 2017[19]. - Net profit attributable to shareholders decreased by 48.77% to ¥36,843,238.80 in 2018 from ¥71,916,262.47 in 2017[19]. - The net profit after deducting non-recurring gains and losses was -¥61,659,649.18, a decline of 206.92% compared to ¥57,667,248.98 in 2017[19]. - The company achieved total operating revenue of ¥422,405,637.01 in 2018, representing a year-on-year growth of 116.70%[40]. - Operating profit for the year was ¥67,788,036.31, a decrease of 17.01% compared to the previous year[40]. - The company reported a total of ¥98,502,887.98 in non-recurring gains for 2018, significantly higher than ¥14,249,013.49 in 2017[25]. - The company reported a total revenue of ¥422,405,637.01 in 2018, representing a 116.70% increase compared to ¥194,929,409.68 in 2017[53]. - The net profit attributable to shareholders was ¥36,843,238.80, with a total profit of ¥60,594,613.03 for the year[53]. - The electric switch industry revenue decreased by 31.45% to ¥80,743,893.31, while the software development industry revenue increased by 64.98% to ¥60,885,165.79[57]. Business Strategy and Expansion - The company plans to expand its business into innovative technology and financial services, aiming for a synergistic development across three main sectors[17]. - The company aims to build an innovative technology ecosystem based on industrial scenarios, integrating cutting-edge talent and quality resources[17]. - The company has established a modern enterprise group integrating smart electrical switch manufacturing, innovative technology software development, and financial services[42]. - The company aims to achieve a combination of "industry scenarios + big data technology + financial service platform" across its three business segments[45]. - The company plans to continue resource sharing and coordinated development among its three business segments to enhance overall value and profitability[46]. - The company is actively expanding its market presence in sectors such as transportation, equipment manufacturing, and smart cities through融钰华通[38]. - The company plans to deepen its traditional business in the intelligent permanent magnet switch industry while seeking strategic cooperation with influential enterprises[101]. - The company is focused on expanding its investment management capabilities through strategic acquisitions and partnerships[91]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% market share by 2020[192]. - A strategic acquisition of a local fintech company is in progress, which is anticipated to add 200 million RMB in annual revenue[192]. Risk Management and Compliance - The company has no significant risk factors that could adversely affect its production, operation, financial status, or profitability[5]. - The company is committed to strict risk management and scientific investment decisions to navigate potential macroeconomic and regulatory challenges[104]. - The company has committed to improving compliance and governance practices following the penalties received, emphasizing adherence to relevant laws and regulations[130]. - The company faced a penalty of 500,000 yuan from the China Securities Regulatory Commission for misleading information disclosure related to a strategic cooperation agreement[129]. - The company has acknowledged the need for better information disclosure management to prevent future regulatory issues[130]. Research and Development - The company aims to expand its product categories and enhance competitiveness through ongoing R&D projects[74]. - The number of R&D personnel increased by 42.86% to 110, representing 13.29% of the total workforce[76]. - R&D expenses rose by 39.91% to ¥10,377,383.03, reflecting the company's commitment to enhancing R&D efforts[71]. - The company is investing 50 million RMB in research and development for new technologies in the payment sector[192]. Shareholder and Governance - The company has a total of 59,112 shareholders at the end of the reporting period, an increase from 56,542 at the previous month-end[168]. - The largest shareholder, Guangzhou Huiyin Rifen Investment Partnership, holds 23.81% of the shares, totaling 200,000,000 shares[168]. - The company has not issued any new securities during the reporting period[166]. - The company has not reported any significant changes in user data or customer metrics in the latest earnings call[198]. - The remuneration for directors, supervisors, and senior management is determined based on their administrative positions and company performance, with year-end bonuses linked to performance evaluations[200]. Social Responsibility - The company has actively participated in social responsibility initiatives, focusing on product safety, environmental protection, and community support[148]. - The company has not initiated any targeted poverty alleviation work during the reporting year[149]. Future Outlook - The company has set a revenue guidance for 2019, projecting an increase of 10% to 1.32 billion RMB[192]. - The management team emphasized a focus on improving customer service, aiming for a 90% customer satisfaction rate by the end of 2019[192]. - The company anticipates significant growth potential in the financial technology industry, driven by the integration of real industries and financial services[101].
皓宸医疗(002622) - 2018 Q3 - 季度财报
2018-10-29 16:00
Financial Performance - Operating revenue for the reporting period was ¥116,501,298.83, representing a year-on-year increase of 122.89%[7] - Net profit attributable to shareholders was ¥17,691,715.39, up 166.28% year-on-year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥16,143,100.09, an increase of 144.86% compared to the same period last year[7] - Basic earnings per share were ¥0.0211, reflecting an increase of 111.00% compared to the same period last year[7] - Operating revenue for the period was ¥286,013,061.43, an increase of 187.09% year-on-year, driven by significant growth in software development and new advertising service revenues[16] - The estimated net profit attributable to shareholders for 2018 is projected to be between 90 million and 125.8 million yuan, representing a year-on-year increase of 25.15% to 74.93% compared to 71.92 million yuan in 2017[24] - The increase in net profit is attributed to gains from the sale of non-operating idle assets and steady growth in the company's two main business segments: innovative technology and financial services[24] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,908,890,520.26, an increase of 10.62% compared to the end of the previous year[7] - The company’s long-term borrowings increased by 48.43% to ¥296,473,682.92, due to new loans taken by subsidiaries[15] - Deferred tax assets increased by 352.01% to ¥36,975,063.48, as the company anticipates significant taxable income from the sale of non-operating idle assets[15] - The company’s other payables rose by 160.12% to ¥77,171,770.78, primarily due to uncompleted real estate transfers[15] Cash Flow - The net cash flow from operating activities was ¥40,596,730.60, a decrease of 136.33% year-on-year[7] - The net cash flow from operating activities was ¥35,209,340.95, an increase of 122.19% year-on-year, mainly due to the recovery of loans in the factoring business[17] - The company's cash and cash equivalents at the end of the period amounted to ¥91,438,907.80, a decrease of 43.44% compared to the beginning of the period, primarily due to the establishment of a new investment fund and payment of equity transfer fees[15] Shareholder Information - The total number of shareholders at the end of the reporting period was 58,613[10] - The largest shareholder, Guangzhou Huiyin Rifen Investment Partnership, held 23.81% of the shares[10] Strategic Initiatives - The company plans to establish an industry merger and acquisition fund with a total scale of ¥1.5 billion, aimed at strategic investments in promising sectors such as intelligent manufacturing and financial technology[18] - The company has completed the private placement fund registration for the industrial merger fund, as announced on August 10, 2018[21] - The company has made significant progress in its strategic initiatives, including the establishment of an industrial merger fund and the termination of unproductive partnerships[21][24] Legal and Regulatory Matters - The company signed a strategic cooperation agreement with China Nuclear Guofinance Investment Group, but later terminated the agreement after confirming the entity's background was not as initially represented[19] - The company has terminated its strategic cooperation with China Nuclear Guofinance Investment Group and initiated legal proceedings against them, as announced on August 6, 2018[21] - The company has received a risk warning regarding an investigation initiated by the China Securities Regulatory Commission, with updates provided on September 8, 2018[22] Research and Development - Research and development expenses totaled ¥7,322,876.24, an increase of 104.82% year-on-year, attributed to higher R&D investments from newly consolidated companies[16] Financial Management - The company has invested a total of 11.77 million yuan in entrusted financial management, with 10.79 million yuan remaining unexpired[28] - The company reported no violations regarding external guarantees or non-operating fund occupation by controlling shareholders during the reporting period[26][27] - The company has not encountered any situations where entrusted financial management is expected to fail in recovering principal or other potential impairment risks[28] Communication and Development Strategy - The company has engaged in various communication activities regarding its future development strategy and the progress of major shareholder agreements throughout July and September 2018[29]
皓宸医疗(002622) - 2018 Q2 - 季度财报
2018-08-28 16:00
Financial Performance - The company's operating revenue for the first half of 2018 was ¥169,511,762.60, representing a 257.94% increase compared to ¥47,357,011.98 in the same period last year[17]. - The net profit attributable to shareholders of the listed company was ¥1,870,770.37, a decrease of 92.42% from ¥24,675,518.92 in the previous year[17]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥177,663.52, down 101.15% from ¥15,447,547.09 in the same period last year[17]. - The net cash flow from operating activities was -¥5,387,389.65, an improvement of 88.52% compared to -¥46,915,894.33 in the previous year[17]. - The total profit for the period was ¥32,005,381.52, with a net profit attributable to shareholders of ¥1,870,770.37[38]. - The total operating revenue for the first half of 2018 reached ¥169,511,762.60, representing a 257.94% increase compared to ¥47,357,011.98 in the same period last year[45]. - The company reported a significant increase in other receivables from CNY 60,932,884.26 to CNY 70,831,338.78, which is an increase of approximately 16.5%[134]. - The company reported a total profit of CNY 32,005,381.52 for the first half of 2018, compared to CNY 25,646,999.67 in the previous year[144]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,807,826,373.06, an increase of 4.76% from ¥1,725,691,693.85 at the end of the previous year[17]. - The total liabilities decreased, with short-term borrowings reduced to ¥35,000,000.00, down from ¥130,000,000.00, reflecting effective debt management[54]. - The company's total liabilities were CNY 488,012,833.73, compared to CNY 470,991,877.35 at the beginning of the period, showing an increase of approximately 3.4%[136]. - The total assets increased to CNY 1,958,028,008.23 from CNY 1,835,973,233.63 year-on-year[141]. - The total equity attributable to the owners of the parent company was CNY 1,239,987,062.49, a slight increase from CNY 1,238,319,207.16, reflecting a growth of about 0.1%[137]. Business Segments - The company operates in three main business segments: industrial, innovative technology, and financial services, with stable development across all segments[25]. - The industrial segment, led by Jilin Yongda Electric Switch Co., focuses on the R&D, production, and sales of permanent magnet switches and high/low voltage switchgear, with a marketing network covering over 20 provinces[25]. - The innovative technology segment includes subsidiaries specializing in big data applications and digital retail management solutions, utilizing project-based and SaaS sales models[26]. - The financial services segment has established subsidiaries for commercial factoring, financing leasing, and investment management, with a focus on integrating financial services with industrial scenarios[27]. - The financial services sector saw a revenue increase of 76.28%, driven by the addition of financing leasing services alongside factoring services, enhancing market recognition and business maturity[48]. Investments and Acquisitions - The company has increased its non-current assets by 50 million yuan due to the prepayment for acquiring 100% equity of Zhongqi Shunxing (Beijing) Investment Management Co., Ltd.[29]. - The company made a significant equity investment of ¥5,490,000 in Ningbo Rongyu Automotive Sales Co., acquiring a 100% stake[58]. - The company established a new investment management firm with an investment of ¥1,000,000, also acquiring a 100% stake[59]. - The company completed the acquisition of 100% equity of Shanghai Landu Investment Management Co., Ltd. by its wholly-owned subsidiary, Rongyu Innovation Investment (Shenzhen) Co., Ltd., which was included in the consolidated financial statements in April 2018[71]. - The acquisition of 51% equity in Zhongyuan Hengxin by Rongyu Group was completed for RMB 50.39 million, enhancing the company's control over its financial services segment[69]. Operational Efficiency and Management - The company has made significant investments in talent acquisition and management to enhance operational efficiency and decision-making capabilities across its business segments[32]. - The company is focusing on enhancing brand image and corporate culture through increased marketing efforts[41]. - The company plans to continue enhancing its financial technology service platform and promote resource sharing among its business segments to improve overall performance[31]. - The company plans to enhance internal controls and improve operational efficiency to steadily increase business performance in the future[74]. Shareholder and Equity Information - The company plans not to distribute cash dividends or issue bonus shares[6]. - The total number of shares remains unchanged at 840,000,000, with a slight adjustment in the proportion of locked shares held by directors and senior management[113]. - The largest shareholder, Guangzhou Huiyin Rifen Investment Partnership, holds 200,000,000 shares, representing 23.81% of the total shares[119]. - The total amount of minority interests at the end of the current period was 16,380,000.00 yuan, showing a stable minority shareholder position[162]. Regulatory and Compliance - The semi-annual financial report has not been audited[82]. - The company has not experienced any major litigation or arbitration matters during the reporting period[85]. - The company has not conducted any major related party transactions during the reporting period[89]. - The company has not reported any significant environmental issues or social responsibility failures in the current period[104][105]. Future Outlook - The company expects a net profit attributable to shareholders for the first three quarters of 2018 to be between 1.59 million RMB and 3.13 million RMB, reflecting a decrease of approximately 96.81% to 49.23% compared to the same period in 2017[74]. - The decline in performance is attributed to increased management expenses due to the expansion of the company's scale and financing costs, as well as investments in strategic areas that are still in the cultivation phase[74]. - The company is building a financial technology service platform that integrates data collection, analysis, and financial services, which may be affected by macroeconomic and regulatory environments[75].
皓宸医疗(002622) - 2018 Q1 - 季度财报
2018-04-26 16:00
1 融钰集团股份有限公司 2018 年第一季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人尹宏伟、主管会计工作负责人邓强及会计机构负责人(会计主管 人员)杨恩龙声明:保证季度报告中财务报表的真实、准确、完整。 融钰集团股份有限公司 2018 年第一季度报告正文 融钰集团股份有限公司 2018 年第一季度报告正文 2018-079 2018 年 4 月 2 融钰集团股份有限公司 2018 年第一季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入(元) | 27,008,944.61 | 12,871,000.83 | 109.84% | | 归属于上市公司股东的净利润(元) | -8,312,871.88 | 6,014,9 ...